Sanofi (SNY) EBT (2009 - 2026)

Sanofi has disclosed EBT across 18 years of filings, most recently posting $2.7 billion for Q1 2026.

• EBT for Q1 2026 came in at $2.7 billion, up 2.43% year-over-year; the trailing twelve-month figure through Mar 2026 was $8.9 billion (down 15.6% YoY), and the FY2025 annual result was $7.2 billion, changed 0.43% from the prior year.
• EBT came in at $2.7 billion for Q1 2026 at Sanofi, up from -$4.9 billion in the prior quarter.
• In the past five years, EBT ranged from a high of $9.3 billion in Q3 2025 to a low of -$4.9 billion in Q4 2025.
• The 5-year median for EBT is $2.7 billion (2026), against an average of $3.0 billion.
• Across the five-year window, EBT soared 27851.11% in 2022 and tumbled 380.21% in 2025, its largest moves.
• Sanofi's EBT stood at $4.6 billion in 2022, then jumped by 91.58% to $8.9 billion in 2023, then plunged by 80.19% to $1.8 billion in 2024, then sank by 380.21% to -$4.9 billion in 2025, then surged by 154.61% to $2.7 billion in 2026.
• The last three EBT figures came in at $2.7 billion (Q1 2026), -$4.9 billion (Q4 2025), and $9.3 billion (Q3 2025), per Business Quant data.